Biotracker is a GLP and US FDA 21 CFR Part 11 compliant laboratory information and knowledge management system integrating with the Affymetrix GeneChip platform
Ocimum Biosolutions says its Biotracker software application has achieved GeneChip-compatible status with the Affymetrix GeneChip microarray platform and that it has agreed to participate in the Affymetrix GeneChip-compatible applications programme, which provides customers with a broad spectrum of software solutions for biomedical research and development.
As a GeneChip-compatible software provider, Ocimum says it is committed to seamlessly integrating Biotracker with the Affymetrix GeneChip platform.
Biotracker is a GLP and US FDA 21 CFR Part 11 compliant laboratory information and knowledge management system.
It is an effective tool for improving laboratory performance which allows analysts to keep track of samples, reagents, instruments, processes, and results at every stage of a project, says the company.
Biotracker is a customised Lims which has various modules, some of which are: laboratory administration module, resource schedule module, project tracking, analysis and result archival module, inventory management and tracking system module, sample tracking module and plate tracking module.
"We are very happy to be part of the GeneChip-compatible applications programme with the market leader in the microarray space.
"Biotracker is a very flexible and configurable program and we understand the Affymetrix platform well to provide users with customised solutions," said Anuradha Acharya, CEO of Ocimum Biosolutions.
"Many of our customers are now applying microarray methods initially developed for basic research into translational medicine and clinical research," said Steve Lincoln, vice president of Informatics at Affymetrix.
"We are pleased to be engaged with leading software providers, including Ocimum Biosolutions, in developing integrated solutions to address these emerging needs".
Ocimum Biosolutions is a life sciences R and D enabling company with three focus areas, Bio-IT, microarrays, and contract research services.
The microarray division of Ocimum has been recently acquired from MWG Biotech.
These include catalogue OciChips, custom OciChips, and hybridisation services.
The Bio-IT division provides key, ready to use reliable, cost-effective software solutions for the biotech/pharma industry with a suite of Lims and bioinformatics products such as Biotracker, Toxchek, Pharmatracker, Genchek, OptGene, Nutrabase, Genowiz, and iRNAchek.
Ocimum also offers custom software for genomics and molecular biology, besides doing data analysis as a service.
The Contract services division provides molecular biology services like GMO testing, DNA extractions, fermentation and gene synthesis.
Through one of the largest third-party software developer communities within the life science industry, Affymetrix works with ADN participants to provide a broad spectrum of solutions for leveraging gene expression and genetic variation analysis in both biomedical research and development.
Membership in ADN is free of charge for both commercial and academic software developers.
Affymetrix scientists invented the world's first microarray in 1989 and began selling the first commercial microarray in 1994.
Since then, Affymetrix GeneChip technology has become the industry standard in molecular biology research.
Affymetrix GeneChip technology is used by the world's top pharmaceutical, diagnostic and biotechnology companies as well as leading academic, government and not-for-profit research institutes.
More than 1200 systems have been shipped around the world and more than 3000 peer-reviewed papers have been published using the technology.
Affymetrix says its patented photolithographic manufacturing process provides the most information capacity available today on a microarray, enabling researchers to use a whole-genome approach to analyse the relationship between genetics and health.
